Catalyst Wire Dossier Catalyst Wire Dossier

FB825

FB825 · Oneness Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for FB825, covering 2016-02-04 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma [Phase 2]

See pricing